Pierre Gerard Cassigneul
Director/Board Member at Enterome SA
Pierre Gerard Cassigneul active positions
Companies | Position | Start | End |
---|---|---|---|
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Director/Board Member | 2012-12-31 | - |
Independent Dir/Board Member | 2012-12-31 | - |
Career history of Pierre Gerard Cassigneul
Former positions of Pierre Gerard Cassigneul
Companies | Position | Start | End |
---|---|---|---|
Stone Bridge Management LLC | Corporate Officer/Principal | 2002-10-31 | 2003-07-31 |
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 2001-01-31 | 2002-06-30 |
Microbiome Diagnostics Partners SA
Microbiome Diagnostics Partners SA BiotechnologyHealth Technology Microbiome Diagnostics Partners SA develops and commercializes microbiome-based diagnostics. The company was founded on August 8, 2017 and is headquartered in Epalinges, Switzerland. | Director/Board Member | - | - |
NMS Labs
NMS Labs Miscellaneous Commercial ServicesCommercial Services NMS Labs provides professional, state-of-the-art laboratory diagnostic services to clinicians, members of the criminal and civil justice communities, and those researching and developing new therapeutics. It offers forensic services, clinical services and research services. The company was founded by Fredric Rieders in 1970 and is headquartered in Willow Grove, PA. | Chief Executive Officer | 2013-11-19 | - |
President | 2013-11-19 | - | |
Predictive Biosciences, Inc.
Predictive Biosciences, Inc. Medical/Nursing ServicesHealth Services Predictive Biosciences is a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty, urology-focused provider of anatomic pathology laboratory products and services. The Company pioneered the Clinical Intervention Determining Diagnostic (CIDD) and Multi-Analyte Diagnostic Readout (MADR) approaches to cancer management, leveraging its portfolio of patented biomarkers and clinical algorithms. Based on these approaches, the Company is building a unique portfolio of assays that enable physicians to reliably determine the presence or absence of cancer with very high levels of confidence. Predictive Biosciences' first tests are targeted toward the growing bladder cancer and prostate cancer survivor populations and the large number of individuals undergoing clinical workups for these malignancies. Predictive Biosciences' corporate headquarters and innovation center is located in Lexington, Massachusetts. The Company's commercial division, OncoDiagnostic Laboratory (ODL), is located in Cleveland, Ohio. ODL is a Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab with a national sales force serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians. Founded in 2006, Predictive Biosciences is privately funded by Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates. | Director/Board Member | 2013-01-03 | - |
Chief Executive Officer | 2013-01-03 | - | |
The Bay Area Bioscience Association | Director/Board Member | - | - |
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Corporate Officer/Principal | - | - |
░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Pierre Gerard Cassigneul
Ecole Supérieure de Commerce de Reims | Undergraduate Degree |
Statistics
International
United States | 9 |
France | 3 |
Switzerland | 2 |
Operational
Director/Board Member | 5 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 8 |
Consumer Services | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
CAREDX, INC | Health Technology |
BECTON, DICKINSON AND COMPANY | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Private companies | 7 |
---|---|
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
Stone Bridge Management LLC | |
The Bay Area Bioscience Association | Health Technology |
Predictive Biosciences, Inc.
Predictive Biosciences, Inc. Medical/Nursing ServicesHealth Services Predictive Biosciences is a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty, urology-focused provider of anatomic pathology laboratory products and services. The Company pioneered the Clinical Intervention Determining Diagnostic (CIDD) and Multi-Analyte Diagnostic Readout (MADR) approaches to cancer management, leveraging its portfolio of patented biomarkers and clinical algorithms. Based on these approaches, the Company is building a unique portfolio of assays that enable physicians to reliably determine the presence or absence of cancer with very high levels of confidence. Predictive Biosciences' first tests are targeted toward the growing bladder cancer and prostate cancer survivor populations and the large number of individuals undergoing clinical workups for these malignancies. Predictive Biosciences' corporate headquarters and innovation center is located in Lexington, Massachusetts. The Company's commercial division, OncoDiagnostic Laboratory (ODL), is located in Cleveland, Ohio. ODL is a Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab with a national sales force serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians. Founded in 2006, Predictive Biosciences is privately funded by Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates. | Health Services |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
NMS Labs
NMS Labs Miscellaneous Commercial ServicesCommercial Services NMS Labs provides professional, state-of-the-art laboratory diagnostic services to clinicians, members of the criminal and civil justice communities, and those researching and developing new therapeutics. It offers forensic services, clinical services and research services. The company was founded by Fredric Rieders in 1970 and is headquartered in Willow Grove, PA. | Commercial Services |
Microbiome Diagnostics Partners SA
Microbiome Diagnostics Partners SA BiotechnologyHealth Technology Microbiome Diagnostics Partners SA develops and commercializes microbiome-based diagnostics. The company was founded on August 8, 2017 and is headquartered in Epalinges, Switzerland. | Health Technology |